Amodiaquine Dosage and Tolerability for Intermittent Preventive Treatment To Prevent Malaria in Children
OA Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Com...
Gespeichert in:
| Veröffentlicht in: | Antimicrobial Agents and Chemotherapy 2010-03, Vol.54 (3), p.1265-1274 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1274 |
|---|---|
| container_issue | 3 |
| container_start_page | 1265 |
| container_title | Antimicrobial Agents and Chemotherapy |
| container_volume | 54 |
| creator | CAIRNS, M CISSE, B SOKHNA, C CAMES, C SIMONDON, K BA, E. H TRAPE, J.-F GAYE, O GREENWOOD, B. M MILLIGAN, P. J. M |
| description | OA
Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
|
| doi_str_mv | 10.1128/AAC.01161-09 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pasca</sourceid><recordid>TN_cdi_proquest_miscellaneous_21497919</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>21497919</sourcerecordid><originalsourceid>FETCH-LOGICAL-a504t-8e5b4f01c983d441ee15b2ca48fd6427be9b236103e1acbf906ab20fb2cb28343</originalsourceid><addsrcrecordid>eNp1kc1v1DAQxS0EotvCjTMyB5CQSLEdOxtfkFbLV6UiOCxna5xMNq4Su7WTRf3v62W3BQ6cxh7_9N6MHyEvODvnXNTvV6v1OeO84gXTj8iCM10XldLVY7JgrKoKWTN5Qk5TumL5rjR7Sk7E_sRUuSD9agytg5vZeaQfQ4ItUvAt3YQBI1g3uOmWdiHSCz9hHN00oZ_oj4i7XN0O6SYiTOO-uQn3ffoNBogOqPN03buhjeifkScdDAmfH-sZ-fn502b9tbj8_uVivbosQDE5FTUqKzvGG12XrZQckSsrGpB111ZSLC1qK8qKsxI5NLbTrAIrWJcZK-pSlmfkw0H3erYjtk0eJ8JgrqMbId6aAM78--Jdb7ZhZ0QtlNbLLPDmKBDDzYxpMqNLDQ4DeAxzMoJLvdRcZ_DdAWxiSCli92DCmdlHY3I05nc0hu3xtwcc0ijMVZijz__wP_bl30s8CN_nloHXRwBSA0MXwTcu_eGEVEJLnrlXB6532_6Xi2iyuwFojJKmNFxUqrwDfXiwJA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21497919</pqid></control><display><type>article</type><title>Amodiaquine Dosage and Tolerability for Intermittent Preventive Treatment To Prevent Malaria in Children</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>CAIRNS, M ; CISSE, B ; SOKHNA, C ; CAMES, C ; SIMONDON, K ; BA, E. H ; TRAPE, J.-F ; GAYE, O ; GREENWOOD, B. M ; MILLIGAN, P. J. M</creator><creatorcontrib>CAIRNS, M ; CISSE, B ; SOKHNA, C ; CAMES, C ; SIMONDON, K ; BA, E. H ; TRAPE, J.-F ; GAYE, O ; GREENWOOD, B. M ; MILLIGAN, P. J. M</creatorcontrib><description>OA
Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.01161-09</identifier><identifier>PMID: 20065053</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Age Factors ; Amodiaquine ; Amodiaquine - administration & dosage ; Amodiaquine - adverse effects ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antimalarials ; Antimalarials - administration & dosage ; Antimalarials - adverse effects ; Biological and medical sciences ; Body Weight ; Child ; Child, Preschool ; Clinical Therapeutics ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Drug Combinations ; Drug Therapy, Combination ; Human protozoal diseases ; Humans ; Infant ; Infectious diseases ; Malaria ; Malaria - prevention & control ; Medical sciences ; Parasitic diseases ; Pharmacology. Drug treatments ; Protozoal diseases ; Pyrimethamine ; Pyrimethamine - administration & dosage ; Pyrimethamine - adverse effects ; Seasons ; Sulfadoxine ; Sulfadoxine - administration & dosage ; Sulfadoxine - adverse effects ; Treatment Outcome</subject><ispartof>Antimicrobial Agents and Chemotherapy, 2010-03, Vol.54 (3), p.1265-1274</ispartof><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 American Society for Microbiology</rights><rights>Copyright © 2010, American Society for Microbiology 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a504t-8e5b4f01c983d441ee15b2ca48fd6427be9b236103e1acbf906ab20fb2cb28343</citedby><cites>FETCH-LOGICAL-a504t-8e5b4f01c983d441ee15b2ca48fd6427be9b236103e1acbf906ab20fb2cb28343</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825997/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825997/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22452941$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20065053$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CAIRNS, M</creatorcontrib><creatorcontrib>CISSE, B</creatorcontrib><creatorcontrib>SOKHNA, C</creatorcontrib><creatorcontrib>CAMES, C</creatorcontrib><creatorcontrib>SIMONDON, K</creatorcontrib><creatorcontrib>BA, E. H</creatorcontrib><creatorcontrib>TRAPE, J.-F</creatorcontrib><creatorcontrib>GAYE, O</creatorcontrib><creatorcontrib>GREENWOOD, B. M</creatorcontrib><creatorcontrib>MILLIGAN, P. J. M</creatorcontrib><title>Amodiaquine Dosage and Tolerability for Intermittent Preventive Treatment To Prevent Malaria in Children</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>AAC</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>OA
Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</description><subject>Age Factors</subject><subject>Amodiaquine</subject><subject>Amodiaquine - administration & dosage</subject><subject>Amodiaquine - adverse effects</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antimalarials</subject><subject>Antimalarials - administration & dosage</subject><subject>Antimalarials - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Body Weight</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Clinical Therapeutics</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Administration Schedule</subject><subject>Drug Combinations</subject><subject>Drug Therapy, Combination</subject><subject>Human protozoal diseases</subject><subject>Humans</subject><subject>Infant</subject><subject>Infectious diseases</subject><subject>Malaria</subject><subject>Malaria - prevention & control</subject><subject>Medical sciences</subject><subject>Parasitic diseases</subject><subject>Pharmacology. Drug treatments</subject><subject>Protozoal diseases</subject><subject>Pyrimethamine</subject><subject>Pyrimethamine - administration & dosage</subject><subject>Pyrimethamine - adverse effects</subject><subject>Seasons</subject><subject>Sulfadoxine</subject><subject>Sulfadoxine - administration & dosage</subject><subject>Sulfadoxine - adverse effects</subject><subject>Treatment Outcome</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1v1DAQxS0EotvCjTMyB5CQSLEdOxtfkFbLV6UiOCxna5xMNq4Su7WTRf3v62W3BQ6cxh7_9N6MHyEvODvnXNTvV6v1OeO84gXTj8iCM10XldLVY7JgrKoKWTN5Qk5TumL5rjR7Sk7E_sRUuSD9agytg5vZeaQfQ4ItUvAt3YQBI1g3uOmWdiHSCz9hHN00oZ_oj4i7XN0O6SYiTOO-uQn3ffoNBogOqPN03buhjeifkScdDAmfH-sZ-fn502b9tbj8_uVivbosQDE5FTUqKzvGG12XrZQckSsrGpB111ZSLC1qK8qKsxI5NLbTrAIrWJcZK-pSlmfkw0H3erYjtk0eJ8JgrqMbId6aAM78--Jdb7ZhZ0QtlNbLLPDmKBDDzYxpMqNLDQ4DeAxzMoJLvdRcZ_DdAWxiSCli92DCmdlHY3I05nc0hu3xtwcc0ijMVZijz__wP_bl30s8CN_nloHXRwBSA0MXwTcu_eGEVEJLnrlXB6532_6Xi2iyuwFojJKmNFxUqrwDfXiwJA</recordid><startdate>20100301</startdate><enddate>20100301</enddate><creator>CAIRNS, M</creator><creator>CISSE, B</creator><creator>SOKHNA, C</creator><creator>CAMES, C</creator><creator>SIMONDON, K</creator><creator>BA, E. H</creator><creator>TRAPE, J.-F</creator><creator>GAYE, O</creator><creator>GREENWOOD, B. M</creator><creator>MILLIGAN, P. J. M</creator><general>American Society for Microbiology</general><general>American Society for Microbiology (ASM)</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>F1W</scope><scope>FR3</scope><scope>H95</scope><scope>H97</scope><scope>L.G</scope><scope>M7N</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20100301</creationdate><title>Amodiaquine Dosage and Tolerability for Intermittent Preventive Treatment To Prevent Malaria in Children</title><author>CAIRNS, M ; CISSE, B ; SOKHNA, C ; CAMES, C ; SIMONDON, K ; BA, E. H ; TRAPE, J.-F ; GAYE, O ; GREENWOOD, B. M ; MILLIGAN, P. J. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a504t-8e5b4f01c983d441ee15b2ca48fd6427be9b236103e1acbf906ab20fb2cb28343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Age Factors</topic><topic>Amodiaquine</topic><topic>Amodiaquine - administration & dosage</topic><topic>Amodiaquine - adverse effects</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antimalarials</topic><topic>Antimalarials - administration & dosage</topic><topic>Antimalarials - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Body Weight</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Clinical Therapeutics</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Administration Schedule</topic><topic>Drug Combinations</topic><topic>Drug Therapy, Combination</topic><topic>Human protozoal diseases</topic><topic>Humans</topic><topic>Infant</topic><topic>Infectious diseases</topic><topic>Malaria</topic><topic>Malaria - prevention & control</topic><topic>Medical sciences</topic><topic>Parasitic diseases</topic><topic>Pharmacology. Drug treatments</topic><topic>Protozoal diseases</topic><topic>Pyrimethamine</topic><topic>Pyrimethamine - administration & dosage</topic><topic>Pyrimethamine - adverse effects</topic><topic>Seasons</topic><topic>Sulfadoxine</topic><topic>Sulfadoxine - administration & dosage</topic><topic>Sulfadoxine - adverse effects</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CAIRNS, M</creatorcontrib><creatorcontrib>CISSE, B</creatorcontrib><creatorcontrib>SOKHNA, C</creatorcontrib><creatorcontrib>CAMES, C</creatorcontrib><creatorcontrib>SIMONDON, K</creatorcontrib><creatorcontrib>BA, E. H</creatorcontrib><creatorcontrib>TRAPE, J.-F</creatorcontrib><creatorcontrib>GAYE, O</creatorcontrib><creatorcontrib>GREENWOOD, B. M</creatorcontrib><creatorcontrib>MILLIGAN, P. J. M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Engineering Research Database</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CAIRNS, M</au><au>CISSE, B</au><au>SOKHNA, C</au><au>CAMES, C</au><au>SIMONDON, K</au><au>BA, E. H</au><au>TRAPE, J.-F</au><au>GAYE, O</au><au>GREENWOOD, B. M</au><au>MILLIGAN, P. J. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Amodiaquine Dosage and Tolerability for Intermittent Preventive Treatment To Prevent Malaria in Children</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>AAC</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2010-03-01</date><risdate>2010</risdate><volume>54</volume><issue>3</issue><spage>1265</spage><epage>1274</epage><pages>1265-1274</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>OA
Classifications
Services
AAC
Citing Articles
Google Scholar
PubMed
Related Content
Social Bookmarking
CiteULike
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
StumbleUpon
Twitter
current issue
AAC
About
AAC
Subscribers
Authors
Reviewers
Advertisers
Inquiries from the Press
Permissions & Commercial Reprints
ASM Journals Public Access Policy
AAC
RSS Feeds
1752 N Street N.W. • Washington DC 20036
202.737.3600 • 202.942.9355 fax • journals@asmusa.org
Print ISSN:
0066-4804
Online ISSN:
1098-6596
Copyright © 2014
by the
American Society for Microbiology.
For an alternate route to
AAC
.asm.org, visit:
AAC
</abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>20065053</pmid><doi>10.1128/AAC.01161-09</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0066-4804 |
| ispartof | Antimicrobial Agents and Chemotherapy, 2010-03, Vol.54 (3), p.1265-1274 |
| issn | 0066-4804 1098-6596 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_21497919 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Age Factors Amodiaquine Amodiaquine - administration & dosage Amodiaquine - adverse effects Antibiotics. Antiinfectious agents. Antiparasitic agents Antimalarials Antimalarials - administration & dosage Antimalarials - adverse effects Biological and medical sciences Body Weight Child Child, Preschool Clinical Therapeutics Dose-Response Relationship, Drug Drug Administration Schedule Drug Combinations Drug Therapy, Combination Human protozoal diseases Humans Infant Infectious diseases Malaria Malaria - prevention & control Medical sciences Parasitic diseases Pharmacology. Drug treatments Protozoal diseases Pyrimethamine Pyrimethamine - administration & dosage Pyrimethamine - adverse effects Seasons Sulfadoxine Sulfadoxine - administration & dosage Sulfadoxine - adverse effects Treatment Outcome |
| title | Amodiaquine Dosage and Tolerability for Intermittent Preventive Treatment To Prevent Malaria in Children |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T22%3A17%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Amodiaquine%20Dosage%20and%20Tolerability%20for%20Intermittent%20Preventive%20Treatment%20To%20Prevent%20Malaria%20in%20Children&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=CAIRNS,%20M&rft.date=2010-03-01&rft.volume=54&rft.issue=3&rft.spage=1265&rft.epage=1274&rft.pages=1265-1274&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/AAC.01161-09&rft_dat=%3Cproquest_pasca%3E21497919%3C/proquest_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21497919&rft_id=info:pmid/20065053&rfr_iscdi=true |